The Effect of Instrument Assisted Soft Tissue Mobilization in Female Patients With Myofascial Pain Syndrome Due to Active Trigger Points in the Upper Trapezius Muscles
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Myofascial Pain
- Sponsor
- Kirsehir Ahi Evran Universitesi
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- Pain Algometer
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The primer aim of this study is to demonstrate the effecti of instrument assisted soft tissue mobilization on pain, functionality, quality of life and depression in the treatment of female patients with myofascial pain syndrome due to active trigger points in the upper trapezius muscles
Detailed Description
Myofascial Pain Syndrome (MAS); It is a non-articular, non-inflammatory regional musculoskeletal pain syndrome characterized by myofascial trigger points located at muscle, fascia or tendon insertion sites and the spread of pain to reference areas by palpation of these points. h The effectiveness of massage therapy in MAS is known. In this study, investigators will apply instrument assisted deep tissue mobilization (graston massage). Instrument-assisted soft tissue mobilization massage, which is a type of massage, will be applied by a physiotherapist who has a certificate on this subject and takes part as an assistant researcher in our study. Soft tissue mobilization is a unique soft tissue mobilization combined with active mobility and stretching exercises already prescribed for patients with musculoskeletal injuries. The various sizes and beveled edges of the stainless steel instruments allow physiotherapists to tailor treatment to different muscle structures facing myofascial constraints. Localized increases in blood flow and soft tissue realignment lead to muscle function, increased normal joint motion, and decreased pain. It has been investigated in the literature for many different diseases (trigger finger, nonspecific low back pain, myofascial pain syndrome) and found to be effective.CF
Investigators
Basak Cigdem Karacay
Assistant professor
Kirsehir Ahi Evran Universitesi
Eligibility Criteria
Inclusion Criteria
- •Being woman and between the ages of 18-45
- •Not to be in menopause
- •Pain in the upper trapezius area
- •Detection of a taut band in the upper trapezius region on examination
- •At least one active trigger point in the tension band in the upper trapezius region on examination
- •The pain caused by the compression of the trigger point is the pain that the patient complains about
- •Painful restriction of cervical lateral flexion motion during stretching
- •Pain 4 or more according to NRS
Exclusion Criteria
- •major surgery or trauma to the musculoskeletal system, especially the spine and upper extremities 2.History of any operation related to the head and neck region
- •Neuromuscular disease
- •History of rheumatic disease, malgnite in the active period
- •Cervical discopathy, cervical spondylosis, pathologies related to the shoulder joint and surrounding soft tissues, scoliosis, kyphosis, leg length difference, polio sequelae, developmental hip dysplasia
- •Psychiatric disease (Beck Depression Inventory score of 30 and above) 6.Obese (BMI≥30 kg/m2)
Outcomes
Primary Outcomes
Pain Algometer
Time Frame: Fourth week (Posttreatment)
The pain threshold level will be measured with an algometer. The algometer manually evaluates the patient's pain threshold and gives a numerical data
Visual Analogue Scale (VAS)
Time Frame: Fourth week (Posttreatment)
Visual Analogue Scale (VAS) for pain assessment. In this scale, which evaluates pain with a 10-point Likert scale, 0 is scored as no pain, 5 as moderate pain, and 10 as excruciating pain.
Number and location of trigger points
Time Frame: Fourth week (Posttreatment)
The number and location of trigger points that cause myofascial pain will be determined and recorded by examination.
Secondary Outcomes
- The neck disability index(Fourth week (Posttreatment))
- The World Health Organization health-related quality of life-brief form(Fourth week (Posttreatment))
- Beck depression questionnaire(Fourth week (Posttreatment))